Stephen Croskrey - Jan 1, 2025 Form 4 Insider Report for Danimer Scientific, Inc. (DNMR)

Role
Director
Signature
/s/ Stephen A. Martin, attorney-in-fact
Stock symbol
DNMR
Transactions as of
Jan 1, 2025
Transactions value $
$0
Form type
4
Date filed
1/3/2025, 04:05 PM
Previous filing
Mar 31, 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DNMR Restricted Stock Units Award $0 +1.13K $0.00 1.13K Jan 1, 2025 Common Stock 1.13K Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Danimer Scientific Class A common stock.
F2 On November 12, 2024, the common stock of Danimer Scientific, Inc. reverse split 1 for 40.
F3 Comprised of a pro-rata award of restricted stock units (RSU) granted as non-employee director compensation under the Danimer Scientific, Inc. 2020 Long-Term Incentive Plan (the "Plan") with each RSU representing the right to receive one share of Danimer Scientific Class A Common Stock. All of these RSU's will vest and become non-forfeitable on July 9, 2025 subject to recipient's continued service as a director of the Company.